Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.55
-0.05-1.92%
At close: Jun 12, 5:00 PM EST
$2.52
-0.03-1.18%
After Hours: Jun 10, 9:25 AM EST
Kiora Pharmaceuticals Inc Analyst Ratings
KPRXNASDAQ
Kiora Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:KPRX | Benzinga
Kiora Pharmaceuticals Inc has a consensus price target of $6 based on the ratings of 2 analysts. The high is $10 issued by HC Wainwright & Co. on September 2, 2025. The low is $2 issued by Maxim Group on August 9, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on September 2, 2025, March 28, 2025, and November 12, 2024, respectively. With an average price target of $10 between HC Wainwright & Co., there's an implied 296.83% upside for Kiora Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Maxim Group
1calculated from analyst ratings
Analyst Ratings for Kiora Pharmaceuticals
Loading calendar...
FAQ
What is the target price for Kiora Pharmaceuticals (KPRX) stock?
The latest price target for Kiora Pharmaceuticals (NASDAQ:KPRX) was reported by HC Wainwright & Co. on September 2, 2025. The analyst firm set a price target for $10.00 expecting KPRX to rise to within 12 months (a possible 296.83% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kiora Pharmaceuticals (KPRX)?
The latest analyst rating for Kiora Pharmaceuticals (NASDAQ:KPRX) was provided by HC Wainwright & Co., and Kiora Pharmaceuticals reiterated their buy rating.
When was the last upgrade for Kiora Pharmaceuticals (KPRX)?
There is no last upgrade for Kiora Pharmaceuticals
When was the last downgrade for Kiora Pharmaceuticals (KPRX)?
There is no last downgrade for Kiora Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Kiora Pharmaceuticals (KPRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kiora Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kiora Pharmaceuticals was filed on September 2, 2025 so you should expect the next rating to be made available sometime around September 2, 2026.
Is the Analyst Rating Kiora Pharmaceuticals (KPRX) correct?
While ratings are subjective and will change, the latest Kiora Pharmaceuticals (KPRX) rating was a reiterated with a price target of $10.00 to $10.00. The current price Kiora Pharmaceuticals (KPRX) is trading at is $2.52, which is out of the analyst’s predicted range.
